CT-based pancreatic radiomics predicts secondary loss of response to infliximab in biologically naïve patients with Crohn’s disease

CT-based pancreatic radiomics predicts secondary loss of response to infliximab in biologically naïve patients with Crohn’s disease

Abstract Objectives Predicting secondary loss of response (SLR) to infliximab (IFX) is paramount for tailoring personalized management regimens. Concurrent pancreatic manifestations in patients with Crohn’s disease (CD) may correlate with SLR to anti-tumor necrosis factor treatment. This work aimed...

Full description

Bibliographic Details
Main Authors: Tian Yang, Jing Feng, Ruchen Yao, Qi Feng, Jun Shen
Format: Article
Language:English
Published: SpringerOpen 2024-03-01
Series:Insights into Imaging
Subjects:
Crohn’s disease
Pancreas
Radiomics
Secondary loss of response
Computed tomography enterography
Online Access:https://doi.org/10.1186/s13244-024-01637-4

Internet

https://doi.org/10.1186/s13244-024-01637-4

Similar Items